Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells

Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells

Cell Transplantation, 2018 · DOI: 10.1177/0963689718766279 · Published: June 1, 2018

Spinal Cord InjuryRegenerative MedicineBiomedical

Simple Explanation

This study explores a new treatment for complete spinal cord injuries (SCI) using collagen scaffolds, called NeuroRegen scaffolds, combined with human umbilical cord mesenchymal stem cells (MSCs). These scaffolds were implanted into the injury site of two patients diagnosed with acute complete SCI. The researchers used a strict method to diagnose the patients as having complete SCI, combining the American Spinal Injury Association (ASIA) Impairment Scale, MRI scans, and nerve electrophysiology. This is important because it helps ensure that the patients truly had complete injuries before treatment. After one year, the patients showed improvements in both sensory and motor functions. One patient could walk with assistance, and the other regained some leg movement. The study suggests this combined approach could be a promising treatment for acute complete SCI.

Study Duration
1 year
Participants
Two acute complete SCI patients
Evidence Level
Not specified

Key Findings

  • 1
    The sensory level expanded below the injury level in both patients, and they regained sense function in bowel and bladder.
  • 2
    The thoracic SCI patient could walk voluntarily with the hip under the help of brace.
  • 3
    The cervical SCI patient could raise his lower legs against the gravity in the wheelchair and shake his toes under control.

Research Summary

This study investigates the transplantation of NeuroRegen scaffolds with human umbilical cord mesenchymal stem cells (MSCs) into two acute complete SCI patients. The patients were diagnosed as complete SCI using strict criteria combining ASIA Impairment Scale, MRI, and nerve electrophysiology. After one year, both patients showed improvement in sensory and motor functions, suggesting that functional scaffolds transplantation could be an effective treatment for acute complete SCI patients.

Practical Implications

Potential Treatment for Complete SCI

The study suggests that NeuroRegen scaffolds with MSCs could offer a new treatment option for acute complete SCI, which currently has limited effective treatments.

Improved Diagnostic Criteria

The combined diagnostic criteria used in this study may improve the accuracy of diagnosing acute complete SCI, leading to more appropriate treatment strategies.

Functional Recovery

The observed functional recovery in patients indicates the potential for improving the quality of life for individuals with severe spinal cord injuries.

Study Limitations

  • 1
    Small sample size (only two patients)
  • 2
    Lack of a control group
  • 3
    Limited long-term follow-up (only 1 year)

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury